Finally, TRAF7’s involvement in multiple signaling pathways (e.g., MEKK3-ERK5, NF-κB, Robo4) poses a challenge for therapeutic targeting, as perturbation of TRAF7 could lead to unintended effects in other cellular contexts, such as immune modulation or tumor suppression. This evidence concerns the gene NFKB1 and neoplasm.